BE2016C041I2 - - Google Patents

Download PDF

Info

Publication number
BE2016C041I2
BE2016C041I2 BE2016C041C BE2016C041C BE2016C041I2 BE 2016C041 I2 BE2016C041 I2 BE 2016C041I2 BE 2016C041 C BE2016C041 C BE 2016C041C BE 2016C041 C BE2016C041 C BE 2016C041C BE 2016C041 I2 BE2016C041 I2 BE 2016C041I2
Authority
BE
Belgium
Prior art keywords
hydroxypyrone
iron
reacting
carboxylic acid
aqueous solution
Prior art date
Application number
BE2016C041C
Other languages
English (en)
Dutch (nl)
Original Assignee
Shield Tx Uk Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Shield Tx Uk Ltd filed Critical Shield Tx Uk Ltd
Publication of BE2016C041I2 publication Critical patent/BE2016C041I2/nl

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D309/00—Heterocyclic compounds containing six-membered rings having one oxygen atom as the only ring hetero atom, not condensed with other rings
    • C07D309/34—Heterocyclic compounds containing six-membered rings having one oxygen atom as the only ring hetero atom, not condensed with other rings having three or more double bonds between ring members or between ring members and non-ring members
    • C07D309/36—Heterocyclic compounds containing six-membered rings having one oxygen atom as the only ring hetero atom, not condensed with other rings having three or more double bonds between ring members or between ring members and non-ring members with oxygen atoms directly attached to ring carbon atoms
    • C07D309/40—Oxygen atoms attached in positions 3 and 4, e.g. maltol
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P7/00—Drugs for disorders of the blood or the extracellular fluid
    • A61P7/06—Antianaemics

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Diabetes (AREA)
  • Hematology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Engineering & Computer Science (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Compounds Of Iron (AREA)
  • Plural Heterocyclic Compounds (AREA)
BE2016C041C 2002-05-18 2016-08-17 BE2016C041I2 (enrdf_load_html_response)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
GBGB0211500.4A GB0211500D0 (en) 2002-05-18 2002-05-18 Method of forming iron hydroxypyrone compounds
PCT/GB2003/001956 WO2003097627A1 (en) 2002-05-18 2003-05-07 Method of forming iron hydroxypyrone compounds

Publications (1)

Publication Number Publication Date
BE2016C041I2 true BE2016C041I2 (enrdf_load_html_response) 2022-08-09

Family

ID=9936987

Family Applications (1)

Application Number Title Priority Date Filing Date
BE2016C041C BE2016C041I2 (enrdf_load_html_response) 2002-05-18 2016-08-17

Country Status (11)

Country Link
US (1) US7459569B2 (enrdf_load_html_response)
EP (1) EP1506183B1 (enrdf_load_html_response)
AT (1) ATE352547T1 (enrdf_load_html_response)
AU (1) AU2003233881A1 (enrdf_load_html_response)
BE (1) BE2016C041I2 (enrdf_load_html_response)
CA (1) CA2483067C (enrdf_load_html_response)
DE (1) DE60311456T2 (enrdf_load_html_response)
ES (1) ES2283771T3 (enrdf_load_html_response)
FR (1) FR16C0033I2 (enrdf_load_html_response)
GB (1) GB0211500D0 (enrdf_load_html_response)
WO (1) WO2003097627A1 (enrdf_load_html_response)

Families Citing this family (16)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US8952061B2 (en) * 2006-08-22 2015-02-10 University Of Virginia Patent Foundation Methods and compounds regulating the erythroid response to iron deficiency
MX2009008281A (es) 2007-02-06 2009-08-25 Medical Res Council Materiales de ion metalico de poli-oxo-hidroxi modificados con ligando, sus usos y procesos para su preparacion.
GB0808835D0 (en) 2008-05-15 2008-06-18 Vitra Pharmaceuticals Ltd Therapeutic compositions
US8536106B2 (en) 2010-04-14 2013-09-17 Ecolab Usa Inc. Ferric hydroxycarboxylate as a builder
GB201101370D0 (en) 2011-01-27 2011-03-09 Iron Therapeutics Holdings Ag Process
GB201404390D0 (en) * 2014-03-12 2014-04-23 Iron Therapeutics Holdings Ag Composition
WO2015198304A1 (en) 2014-06-22 2015-12-30 Dexcel Pharma Technologies Ltd. Pharmaceutical compositions comprising ferric citrate and methods for the production thereof
GB2531742B (en) * 2014-10-28 2016-10-05 Iron Therapeutics Holdings Ag Polymorphs of ferric maltol
GB201517893D0 (en) 2015-10-09 2015-11-25 Medical Res Council Methods for producing carboxylate ligand modified ferric iron hydroxide colloids
AU2017242905B2 (en) * 2016-03-31 2020-10-22 Shield TX (UK) Limited Methods for producing ferric maltol compositions from elemental iron
CA3019478C (en) 2016-03-31 2024-02-13 United Kingdom Research And Innovation Ferric maltol compositions for use in the treatment or prevention of cancer and tumours
EP3436442B1 (en) * 2016-03-31 2020-10-28 Shield TX (UK) Limited Methods for producing ferric maltol compositions from ferrous hydroxides
WO2017167963A1 (en) * 2016-03-31 2017-10-05 Medical Research Council Methods for producing ferric maltol compositions from ligand modified and ligand coated ferric hydroxides
GB202005054D0 (en) 2020-04-06 2020-05-20 Nemysis Ltd Carboxylate Ligand Modified Ferric Iron Hydroxide Compositions for Use in the Treatment or Prevention of Iron Deficiency Associated with Liver Diseases
CN112574158B (zh) * 2020-12-29 2022-08-02 南京百泽医药科技有限公司 一种麦芽酚铁晶型ii及其制备方法
CN115177625A (zh) * 2022-06-28 2022-10-14 金陵药业股份有限公司 一种羧基麦芽糖铁药用组合物及其制备方法

Family Cites Families (25)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3130204A (en) * 1962-02-07 1964-04-21 Pfizer & Co C Preparation of gamma-pyrones
FR1500765A (fr) * 1963-09-19 1967-11-10 Pfizer & Co C Dérivés de l'acide pyroméconique et procédé pour leur préparation
SE322866B (enrdf_load_html_response) * 1966-12-15 1970-04-20 Astra Ab
US4018907A (en) * 1975-08-25 1977-04-19 General Foods Corporation Coloring food with iron-complexes
US4212685A (en) * 1978-12-11 1980-07-15 Lea Manufacturing Company Protective and color receptive coating for aluminum
US4279936A (en) * 1979-09-24 1981-07-21 William Underwood Company Maltol treated canned meat process
GR78491B (enrdf_load_html_response) 1982-03-24 1984-09-27 Nat Res Dev
CY1501A (en) * 1982-03-24 1990-08-03 Nat Res Dev Pharmaceutical compositions containing a complex of iron with n-substituted 3-hydroxypyrid-2-one or-4-one derivatives
EP0107458B1 (en) 1982-10-22 1987-07-29 National Research Development Corporation Pharmaceutical compositions
GB8308054D0 (en) * 1983-03-24 1983-05-05 Hider R C Pharmaceutical compositions
GB8308055D0 (en) * 1983-03-24 1983-05-05 Hider R C Pharmaceutical compositions
USRE34313E (en) 1983-09-23 1993-07-13 National Research Development Corporation Pharmaceutical compositions
US4912118A (en) 1983-09-23 1990-03-27 National Research Development Corporation Pharmaceutical compositions
GB8325494D0 (en) 1983-09-23 1983-10-26 Hider R C Pharmaceutical compositions
GB8325496D0 (en) * 1983-09-23 1983-10-26 Hider R C Pharmaceutical compositions
GB8329043D0 (en) * 1983-10-31 1983-11-30 Hider R C Pharmaceutical compositions
GB8410290D0 (en) 1984-04-19 1984-05-31 Callingham B A Pharmaceutical compositions
GB8410289D0 (en) 1984-04-19 1984-05-31 Callingham B A Pharmaceutical compositions
US5177068A (en) 1984-04-19 1993-01-05 National Research Development Corporation Pharmaceutical compositions
GB8606913D0 (en) 1986-03-20 1986-04-23 Hider R C Treatment of sickle cell disease
JPH0367565A (ja) 1989-08-07 1991-03-22 Kansai Paint Co Ltd 鉄分強化食品
GB9209078D0 (en) 1992-04-27 1992-06-10 Hider Robert C Pharmaceutical compositions
GB9217099D0 (en) 1992-08-12 1992-09-23 British Tech Group Pharmaceutical compositions
EP0833627B1 (en) 1995-06-10 2004-08-18 Vitra Pharmaceuticals Ltd. Iron compounds, compositions, methods of making the same and uses thereof
GB9621273D0 (en) 1996-10-11 1996-11-27 Cortecs Ltd Therapeutic method

Also Published As

Publication number Publication date
GB0211500D0 (en) 2002-06-26
AU2003233881A1 (en) 2003-12-02
ES2283771T3 (es) 2007-11-01
ATE352547T1 (de) 2007-02-15
CA2483067A1 (en) 2003-11-27
DE60311456T2 (de) 2007-11-15
US7459569B2 (en) 2008-12-02
FR16C0033I1 (enrdf_load_html_response) 2016-09-23
US20050250754A1 (en) 2005-11-10
EP1506183A1 (en) 2005-02-16
DE60311456D1 (de) 2007-03-15
CA2483067C (en) 2011-04-26
FR16C0033I2 (fr) 2018-01-19
WO2003097627A1 (en) 2003-11-27
EP1506183B1 (en) 2007-01-24

Similar Documents

Publication Publication Date Title
BE2016C041I2 (enrdf_load_html_response)
EP2272825A3 (en) N-Protected amino hydroxy adamantane carboxylic acid and process for its preparation
ZA200308319B (en) Method for producing an aqueous acrylamide solution with a biocatalyst.
AU2001281028A1 (en) Dilute acid/metal salt hydrolysis of lignocellulosics
MXPA01002392A (es) Metodos y composiciones acidificadas para reducir la corrosion en las superficies de metal y la precipitacion del sulfuro.
MXPA03000510A (es) Sales estables de acido o-acetilsalicilico con aminoacidos basicos.
WO2002076378A3 (es) Proceso para producir un hidróxido cúprico estable y sales cúpricas básicas
AU3309995A (en) Water soluble cyclic amine-dicarboxylic acid-alkanol amine salt corrosion inhibitor
WO2003088956A8 (en) Method for treating ileus with an alpha -ketoalkanoic acid or - ester or - amide
WO2003062344A3 (en) Acidizing and scale treatment of subterranean formation
RS50685B (sr) Koncentrovani vodeni rastvor ambroksola
PL365213A1 (en) Enteric ketoacid salts and amino acids
IL157495A0 (en) Method for the production of d-panthothenic acid and/or salts thereof as adjunct for animal feedstuffs
WO2004095921A3 (en) Sporicidal composition
WO2002024001A3 (de) Tierfuttersupplement enthaltend d-pantothensäure und/oder deren salze, verbessertes verfahren zu dessen herstellung sowie dessen verwendung
IL157402A0 (en) Method for producing d-pantothenic acid and/or salts therefor as an additive for animal feed
IN2003CH01298A (en) Method for producing D-pantothenic acid and/or salt thereof as additive for animal feesdstuffs
IN2003CH01315A (en) Method for producing D-pantothenic acid and/or salts thereof as an additive for animal feed
AU2002250978A1 (en) Method for producing D-pantothenic acid and/or salts thereof as an additive for animal feed
BG102347A (en) New carboxylic acid derivatives, method for their preparation and application
RU2000109795A (ru) Способ получения магнитоактивного соединения
YU71302A (sh) Postupak za formiranje amidne veze
MY134147A (en) Method for stoping hysteresis
MXPA04000513A (es) Proceso para la preparacion de 4-metilamino-4-fenilpiperidina.
ZA947052B (en) Intravenously administrable aqueous solution